What we are finding is that a lot of these companies are not doing the manufacturing, and so it is a very new and interesting business model, and I am convinced that it is one that is really negative for patients, providers, hospitals, and for Federal and State health care programs.
Expressing concerns about the negative effects of new pharmaceutical business models on healthcare.
Share
More from Susan Collins
While the investigation of the Biddeford shooting is not yet complete, it raises sufficient critical questions that I spoke with DHS Secretary Mullin last night and urged him to cease all non-urgent vehicle stops.
the fact remains that there are must-pay bills and urgent requirements facing the department that affect the ability of our troops to be well trained and more broadly of the U.S. military to deter and defend against potential aggressors…
If the Administration proceeds with these tariffs, they will increase costs for Maine families, as most businesses will have no choice but to pass on the tariffs to their customers through higher prices.
While I agree these principles should guide the administration and oversight of Federal funds, the rule would impose new, burdensome requirements on award recipients … and conflict with Congress’ control over the federal funding process.
Other voices in this conversation
